Ipsen S.A.
IPSEYOTCHealthcare● Active
$46.75
+$1.71(+3.80%)
Market Cap$61.8B
P/E Ratio—
52W High$51.1
52W Low$28.655
Ipsen S.A. (IPSEY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IPSEY · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 12, 2026EPS Actual
$1.79
Est. $1.64 · +9.2%
Revenue
$2.37B
Est. $2.26B · +4.6%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 12, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
IPSEY reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | $1.76 | — | — | — | $2.41B | — |
| ▲ Q1 FY2026 | Feb 12, 2026 | $1.64 | $1.79 | +9.2% | $2.37B | $2.26B | +4.6% |
| ▼ Q2 FY2025 | Jun 30, 2025 | $1.63 | $1.18 | -27.6% | $2.28B | $2.20B | +3.9% |
| — Q4 FY2024 | Dec 31, 2024 | — | $0.35 | — | $1.89B | — | — |
| ▼ Q2 FY2024 | Jun 29, 2024 | $1.26 | $0.75 | -40.7% | $1.88B | $1.84B | +2.6% |
| ▲ Q4 FY2023 | Dec 31, 2023 | $1.42 | $1.48 | +4.2% | $1.75B | $1.87B | -6.6% |
| ▼ Q2 FY2023 | Jun 30, 2023 | $1.37 | $0.64 | -53.2% | $1.68B | $1.68B | -0.2% |
| ▼ Q4 FY2022 | Dec 31, 2022 | $1.34 | $0.82 | -38.4% | $1.71B | $1.75B | -1.9% |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
$1.76
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 12, 2026Beat
EPS Actual
$1.79
EPS Est.
$1.64
EPS Surpr.
+9.2%
Revenue
$2.37B
Q2 FY2025
Jun 30, 2025Miss
EPS Actual
$1.18
EPS Est.
$1.63
EPS Surpr.
-27.6%
Revenue
$2.28B
Q4 FY2024
Dec 31, 2024
EPS Actual
$0.35
EPS Est.
—
EPS Surpr.
—
Revenue
$1.89B
Q2 FY2024
Jun 29, 2024Miss
EPS Actual
$0.75
EPS Est.
$1.26
EPS Surpr.
-40.7%
Revenue
$1.88B
Q4 FY2023
Dec 31, 2023Beat
EPS Actual
$1.48
EPS Est.
$1.42
EPS Surpr.
+4.2%
Revenue
$1.75B
Q2 FY2023
Jun 30, 2023Miss
EPS Actual
$0.64
EPS Est.
$1.37
EPS Surpr.
-53.2%
Revenue
$1.68B
Q4 FY2022
Dec 31, 2022Miss
EPS Actual
$0.82
EPS Est.
$1.34
EPS Surpr.
-38.4%
Revenue
$1.71B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2026 | $1.1B | $1.1B | $1.1B | 1 |
| Q1 FY2026 | $0.9B | $0.9B | $0.9B | 1 |
| Q4 FY2025 | $0.9B | $0.9B | $0.9B | 1 |
| Q3 FY2025 | $0.8B | $0.8B | $0.8B | 2 |
| Q2 FY2025 | $0.8B | $0.8B | $0.8B | 1 |
| Q1 FY2025 | $0.8B | $0.8B | $0.8B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Feb 12, 2026 | +9.2% | $40.46 | $44.14 | +9.10% |
| ▼ Q2 FY2025 | Jun 30, 2025 | -27.6% | $29.05 | $30.15 | +3.79% |
| — Q4 FY2024 | Dec 31, 2024 | — | $29.30 | $28.97 | -1.13% |
| ▼ Q2 FY2024 | Jun 29, 2024 | -40.7% | $30.16 | $30.28 | +0.40% |
| ▲ Q4 FY2023 | Dec 31, 2023 | +4.2% | $29.48 | $29.94 | +1.56% |
| ▼ Q2 FY2023 | Jun 30, 2023 | -53.2% | $30.24 | $30.62 | +1.26% |
| ▼ Q4 FY2022 | Dec 31, 2022 | -38.4% | $26.88 | $26.88 | +0.00% |
| ▲ Q2 FY2022 | Jun 30, 2022 | +11.7% | $22.91 | $22.99 | +0.35% |
Q1 FY2026+9.10%
Report Date
Feb 12, 2026
EPS Beat/Miss
+9.2%
Price Before
$40.46
Price After
$44.14
Q2 FY2025+3.79%
Report Date
Jun 30, 2025
EPS Beat/Miss
-27.6%
Price Before
$29.05
Price After
$30.15
Q4 FY2024-1.13%
Report Date
Dec 31, 2024
EPS Beat/Miss
—
Price Before
$29.30
Price After
$28.97
Q2 FY2024+0.40%
Report Date
Jun 29, 2024
EPS Beat/Miss
-40.7%
Price Before
$30.16
Price After
$30.28
Q4 FY2023+1.56%
Report Date
Dec 31, 2023
EPS Beat/Miss
+4.2%
Price Before
$29.48
Price After
$29.94
Q2 FY2023+1.26%
Report Date
Jun 30, 2023
EPS Beat/Miss
-53.2%
Price Before
$30.24
Price After
$30.62
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
-38.4%
Price Before
$26.88
Price After
$26.88
Q2 FY2022+0.35%
Report Date
Jun 30, 2022
EPS Beat/Miss
+11.7%
Price Before
$22.91
Price After
$22.99
Avg Beat Reaction+3.67%
Avg Miss Reaction+1.36%
Beat Rate3 / 8 quarters
Largest Move+9.10% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IPSEY ends December
Ipsen S.A. (IPSEY) most recently reported earnings on February 12, 2026 for Q1 FY2026, posting EPS of $1.79 — beating the analyst consensus of $1.64 by +9.2%. The next IPSEY earnings date is expected around September 1, 2026.
Each quarter, investors track IPSEY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IPSEY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IPSEY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IPSEY earnings · 5 questionsIpsen S.A.'s next earnings report is expected around September 1, 2026. IPSEY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IPSEY historically reports after market close (AMC).
IPSEY earnings datewhen is IPSEY earningsIPSEY next earnings datewhen does IPSEY report earningsIPSEY earnings calendar
▸ Source: FMP · Ipsen S.A. SEC filings · US GAAP · Ipsen S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026